Witte Orthopaedics Ltd 14939731 false 2023-06-16 2024-06-30 2024-06-30 The principal activity of the company is the provision of veterinary services. Digita Accounts Production Advanced 6.30.9574.0 true 14939731 2023-06-16 2024-06-30 14939731 2024-06-30 14939731 core:CurrentFinancialInstruments core:WithinOneYear 2024-06-30 14939731 core:FurnitureFittingsToolsEquipment 2024-06-30 14939731 bus:Micro-entities 2023-06-16 2024-06-30 14939731 bus:AuditExemptWithAccountantsReport 2023-06-16 2024-06-30 14939731 bus:FullAccounts 2023-06-16 2024-06-30 14939731 bus:SmallCompaniesRegimeForAccounts 2023-06-16 2024-06-30 14939731 bus:RegisteredOffice 2023-06-16 2024-06-30 14939731 bus:Director1 2023-06-16 2024-06-30 14939731 bus:PrivateLimitedCompanyLtd 2023-06-16 2024-06-30 14939731 core:FurnitureFittingsToolsEquipment 2023-06-16 2024-06-30 14939731 countries:EnglandWales 2023-06-16 2024-06-30 iso4217:GBP xbrli:pure

Registration number: 14939731

Prepared for the registrar

Witte Orthopaedics Ltd

Unaudited Financial Statements

for the Period from 16 June 2023 to 30 June 2024

 

Witte Orthopaedics Ltd

Contents

Company Information

1

Balance Sheet

2 to 3

 

Witte Orthopaedics Ltd

Company Information

Director

P G Witte

Registered office

101 Pilson Drive
Poole
Dorset
BH17 9HT

Accountants

Hazlewoods LLP
Staverton Court
Staverton
Cheltenham
GL51 0UX

 

Witte Orthopaedics Ltd

(Registration number: 14939731)
Balance Sheet as at 30 June 2024

2024
£

Fixed assets

4,501

Current assets

34,002

Creditors: Amounts falling due within one year

(28,917)

Net current assets

5,085

Total assets less current liabilities

9,586

Accruals and deferred income

(1,950)

 

7,636

Capital and reserves

7,636

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
101 Pilson Drive
Poole
Dorset
BH17 9HT

Basis of preparation

The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

The presentational currency of the financial statements is Pounds Sterling, being the functional currency of the primary economic environment in which the company operates. Monetary amounts in these financial statements are rounded to the nearest Pound.

Staff numbers

The average number of persons employed by the company (including the director) during the period, was as follows:

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

For the financial period ending 30 June 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

Approved and authorised by the director on 6 November 2024
 

 

Witte Orthopaedics Ltd

(Registration number: 14939731)
Balance Sheet as at 30 June 2024

.........................................
P G Witte
Director

 

Witte Orthopaedics Ltd

Detailed Balance Sheet for the Period from 16 June 2023 to 30 June 2024

 

Fixed assets

Furniture, fittings and equipment
 £

Total
£

Cost

Additions

6,002

6,002

At 30 June 2024

6,002

6,002

Depreciation

Charge for the

1,501

1,501

At 30 June 2024

1,501

1,501

Carrying amount

At 30 June 2024

4,501

4,501

 

Current assets

30 June 2024
 £

Trade and other receivables

4,600

Other debtors

21,967

Cash and short-term deposits

7,435

 

34,002

 

Creditors: Amounts falling due within one year

30 June 2024
 £

Trade payables

336

Social security and other taxes

28,581

28,917

 

Accruals and deferred income

30 June 2024
 £

Accrued expenses

1,950